- Small-Cap Stock Portfolio <span style=' color: rgb(255, 255, 255); text-shadow: 2px 2px 1px #1b1b1b; font-size: 40px;'>Apollo Medical Holdings<br /><em style='font-weight:400; font-size:34rem;'>(NASDAQ: AMEH)</em></span><br /> -

Apollo Medical Holdings

 Fact Sheet  Research Report

Apollo Medical Holdings (“ApolloMed” or “AMEH”) is founded in 2001 and headquartered in Glendale, California, ApolloMed (NASDAQ: AMEH) is a leading physician-centric integrated population health management company working to provide coordinated, outcomes-based high-quality medical care for patients, particularly senior patients and patients with multiple chronic conditions, in a cost-effective manner. Led by a management team with over a decade of experience, ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated health management and healthcare delivery platform that includes: Apollo Medical Management (Management Services Organization), ApolloMed Hospitalists, APA ACO (Next Generation ACO), ApolloMed ACO (MSSP Accountable Care Organization), Maverick Medical Group (Independent Physician Association), Apollo Care Connect (Digital Population Health Management Platform) and ApolloMed Palliative Services (Hospice/Palliative Care and Home Health Care). ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care.

Investment HighlightsValue Proposition
Company Name Apollo Medical Holdings
Market/Symbol NASDAQ: AMEH
Industry healthcare
Recent Price
Market Cap$700.67M
Shares Outstanding$34.28M
Avg. Daily Vol. (3m)37,089
Price/Cash Flow 7x
As of Mar. 18, 2019
*Source: QuoteMedia



Recent Company Videos

Apollo Medical: A Leader in the Shift to Accountable Healthcare

Oct. 26, 2015

Apollo Medical Holdings (OTC: AMEH) presents at the October 2015 RedChip Global Online Microcap Conference. Learn more at: ...

Investment Highlights

  • Additional scale will improve margins and help with patient risk and infrastructure costs
  • At scale, we are projecting AMEH to operate at approximately 12%-15% EBITDA margins. We project the Company will be able to reach this at about $150 million in revenue

  • Medicare and Medicaid spending was over $1.0 trillion in 2013

  • Received a $5.38 million revenue distribution in year one from the Centers for Medicare & Medicaid Services as a result of the savings; second highest revenue distribution received in the state of California, and the 25th highest distribution in the United States
  • Potential to receive this distribution every year

AMEH expertise in high-risk and elderly patients population groups accounts for the majority of healthcare costs and allows for potential financial differentiation

Value Proposition

Increases in healthcare costs and the passing of the ACA have driven the need for companies that can both improve the quality of healthcare given and contain healthcare costs. Integrated healthcare services can deliver a coordinated approach that provides the best outcomes for patients and physicians, along with maximizing the value of each of the Company’s physician groups. M&A activity by several large healthcare companies (Fresenius’s majority acquisition of Sound Physicians and Cogent, Rite Aid’s purchase of Urgent Care Centers, Humana’s acquisition of Metropolitan Health Network, and DaVita’s acquisition of HealthCare Partners), underscores the healthcare industry’s move toward an integrated care model. We are valuing AMEH using a 2.1x EV/S multiple applied to our FY16E revenue per share of $13.93, giving us a target price of $29.00. We believe that value-based healthcare models offer high potential revenue growth going forward and that AMEH will deliver strong EBITDA and net income as its business begins to mature and reach scale.

Apollo Medical Holdings Latest News

Latest Investor Presentation

Latest Investor Presentation


AMEH Research

Apollo Medical Holdings (“ApolloMed” or “AMEH”) is a leading population management and physician healthcare delivery company. Apollo provides medical management and care coordination for… Read More

Dec. 04, 2015

AMEH completes $10 million strategic equity investment with Network Medical Management; majority of debt retired. On October 15, 2015, AMEH announced that it had completed a $10 million… Read More

Oct. 21, 2015

For over two decades RedChip Companies has been writing research on small-cap stocks. RedChip was the first to put independent research coverage on Starbucks in 1992. Our research analysts, CFAs, include financial models and target prices based on industry competitors. Our analysts cover dozens of stocks with a focus on healthcare, technology, social media, and consumer goods.

RedChip Companies research reports are distributed to 60,000 opt-in retail, institutional, and accredited investors.

Receive AMEH Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market